Blauvelt, A., Kempers, S., Forman, S., Lain, E. and Bruce, S. 2020. Tirbanibulin Ointment 1%, a Novel Inhibitor of Tubulin Polymerization and Src Kinase Signaling , for the Treatment of Actinic Keratosis (AK): Results from Two Pivotal Phase III Studies. SKIN The Journal of Cutaneous Medicine. 4, 5 (Sep. 2020), s63. DOI:https://doi.org/10.25251/skin.4.supp.62.